These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9062669)

  • 1. Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease.
    Yamada K; Nitta A; Hasegawa T; Fuji K; Hiramatsu M; Kameyama T; Furukawa Y; Hayashi K; Nabeshima T
    Behav Brain Res; 1997 Feb; 83(1-2):117-22. PubMed ID: 9062669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral administration of NGF synthesis stimulators recovers reduced brain NGF content in aged rats and cognitive dysfunction in basal-forebrain-lesioned rats.
    Nabeshima T; Nitta A; Fuji K; Kameyama T; Hasegawa T
    Gerontology; 1994; 40 Suppl 2():46-56. PubMed ID: 7926866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nerve growth factor strategy and preparation of animal model for Alzheimer-type senile dementia].
    Nabeshima T
    Yakugaku Zasshi; 1995 Jul; 115(7):499-512. PubMed ID: 7562397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of propentofylline, a stimulator of nerve growth factor (NGF) synthesis, recovers cholinergic neuronal dysfunction induced by the infusion of anti-NGF antibody into the rat septum.
    Nitta A; Ogihara Y; Onishi J; Hasegawa T; Furukawa S; Nabeshima T
    Behav Brain Res; 1997 Feb; 83(1-2):201-4. PubMed ID: 9062684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of idebenone induces nerve growth factor in the brain and improves learning and memory in basal forebrain-lesioned rats.
    Nitta A; Murakami Y; Furukawa Y; Kawatsura W; Hayashi K; Yamada K; Hasegawa T; Nabeshima T
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Apr; 349(4):401-7. PubMed ID: 8058112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propentofylline prevents neuronal dysfunction induced by infusion of anti-nerve growth factor antibody into the rat septum.
    Nitta A; Ogihara Y; Onishi J; Hasegawa T; Furukawa S; Nabeshima T
    Eur J Pharmacol; 1996 Jun; 307(1):1-6. PubMed ID: 8831096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of learning and memory and the accessory symptom in aged rat as senile dementia model (3): Oral administration of propentofylline produces recovery of reduced NGF content in the brain of aged rats.
    Nabeshima T; Nitta A; Hasegawa T
    Yakubutsu Seishin Kodo; 1993 Jun; 13(3):89-95. PubMed ID: 8237137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral administration of idebenone, a stimulator of NGF synthesis, recovers reduced NGF content in aged rat brain.
    Nitta A; Hasegawa T; Nabeshima T
    Neurosci Lett; 1993 Dec; 163(2):219-22. PubMed ID: 8309637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats.
    Nitta A; Murase K; Furukawa Y; Hayashi K; Hasegawa T; Nabeshima T
    Eur J Pharmacol; 1993 Nov; 250(1):23-30. PubMed ID: 8119322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propentofylline improves learning and memory deficits in rats induced by beta-amyloid protein-(1-40).
    Yamada K; Tanaka T; Senzaki K; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1998 May; 349(1):15-22. PubMed ID: 9669491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of propentofylline, a NGF synthesis stimulator, on alterations in muscarinic cholinergic receptors induced by basal forebrain lesion in rats.
    Fuji K; Hiramatsu M; Hayashi S; Kameyama T; Nabeshima T
    Neurosci Lett; 1993 Feb; 150(1):99-102. PubMed ID: 8469410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats.
    Fuji K; Hiramatsu M; Kameyama T; Nabeshima T
    Eur J Pharmacol; 1993 Jun; 236(3):411-7. PubMed ID: 8359199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve growth factor and Alzheimer's disease.
    Scott SA; Crutcher KA
    Rev Neurosci; 1994; 5(3):179-211. PubMed ID: 7889213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor induces galanin gene expression in the rat basal forebrain: implications for the treatment of cholinergic dysfunction.
    Planas B; Kolb PE; Raskind MA; Miller MA
    J Comp Neurol; 1997 Mar; 379(4):563-70. PubMed ID: 9067843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease.
    Goedert M; Fine A; Dawbarn D; Wilcock GK; Chao MV
    Brain Res Mol Brain Res; 1989 Jan; 5(1):1-7. PubMed ID: 2538704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical studies on functional proteins in the brain nervous system. Neurobiochemical studies on nerve growth factor].
    Hayashi K
    Yakugaku Zasshi; 1996 Apr; 116(4):286-308. PubMed ID: 8709005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor and Alzheimer's disease.
    Hefti F; Weiner WJ
    Ann Neurol; 1986 Sep; 20(3):275-81. PubMed ID: 3532929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor is a neurotrophic factor for forebrain cholinergic neurons; implications for Alzheimer's disease.
    Hefti F; Will B
    J Neural Transm Suppl; 1987; 24():309-15. PubMed ID: 2824691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental change in the nerve growth factor action from induction of choline acetyltransferase to promotion of cell survival in cultured basal forebrain cholinergic neurons from postnatal rats.
    Hatanaka H; Tsukui H; Nihonmatsu I
    Brain Res; 1988 Mar; 467(1):85-95. PubMed ID: 3359332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain.
    Mufson EJ; Bothwell M; Kordower JH
    Exp Neurol; 1989 Sep; 105(3):221-32. PubMed ID: 2548888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.